Skip to main content
SleepCited

オメガ3脂肪酸 不眠症

A

合計37,338名の参加者を対象とした93件の研究(メタアナリシス9件、RCT 18件を含む)に基づく。93件中67件の研究で肯定的な効果が示されている。

<\/script>\n
`; }, get iframeSnippet() { const domain = 'sleepcited.com'; const params = 'ingredient\u003Domega\u002D3\u0026condition\u003Dinsomnia'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

結論

Omega-3 fatty acids are supported by a large body of research suggesting they may help improve sleep quality, particularly for people whose sleep issues are connected to inflammation or mood.

  • 93 studies with 37,338 participants — a very large evidence base
  • 9 meta-analyses and 18 RCTs provide strong, high-quality evidence
  • About 72% of studies show positive effects on sleep
  • May work through anti-inflammatory pathways and support of serotonin/melatonin production

Key Study Findings

animal experimental study
Lavender improves sleep through olfactory perception and GABAergic neurons of the central amygdala.
Dose: LEO 25.0% concentration via inhalation during light phase vs: Placebo 効果: LEO 25% significantly shortened NREM sleep latency, increased NREM sleep, decreased wakefulness; com None
preclinical animal/in vitro study
Ashwagandha (Withania somnifera (L.) dunal) root extract containing withanolide a alleviates depression-like behavior in mice …
Dose: 60 and 100 mg/kg (mice); 100 and 200 µg/mL (HT-22 cells); withanolide A 1.56 and 3.12 µg/mL vs: Placebo 効果: None None
review
Unraveling the connection between the Mediterranean diet and sleep health: from biological mechanisms to clinical …
Dose: Mediterranean diet (high adherence vs. low adherence); polyphenols, omega-3, fiber as key components vs: Placebo 効果: None None
review
[Nutrition in improving sleep quality and fighting insomnia].
Dose: tryptophan, carbohydrates, omega-3, vitamins (B6, B12, folate, niacin, D, C, beta-carotene), mineral vs: Placebo 効果: None None
RCT n=90 12 weeks Double-blind
A New Ashwagandha Formulation (Zenroot™) Alleviates Stress and Anxiety Symptoms While Improving Mood and Sleep …
Dose: 125 mg Zenroot (Ashwagandha with 1.5% total withanolides) daily vs: Placebo 効果: None < 0.05
Case Report n=1
Unmasking Potential Withdrawal Effects of Ashwagandha: A Case Report and Review.
Dose: Ashwagandha extract 600 mg/day (prior to discontinuation) vs: Placebo 効果: None None

Key Statistics

93

研究数

37338

参加者数

Positive

A

グレード

Referenced Papers

Naunyn-Schmiedeberg's archives of … 2025 4 件の引用
Journal of ethnopharmacology 2024 6 件の引用
International journal of … 2023 43 件の引用
Child and adolescent … 2023 5 件の引用
Neurologia 2022 78 件の引用
Neurologia 2022 47 件の引用
Journal of ethnopharmacology 2020 85 件の引用
Nutrients 2020 56 件の引用
The Cochrane database … 2019 24 件の引用
Journal of biotechnology 2017 25 件の引用
Annual review of … 2016 557 件の引用
Sleep medicine reviews 2015 152 件の引用
The Cochrane database … 2014 131 件の引用
Biological & pharmaceutical … 2014 110 件の引用
The Cochrane database … 2014 56 件の引用
Child and adolescent … 2014 42 件の引用
Profiles of drug … 2013 26 件の引用
Journal of pineal … 2012 322 件の引用
Anaesthesia and intensive … 2011 18 件の引用
Molecular medicine reports 2010 398 件の引用
Phytomedicine : international … 2010 148 件の引用
Journal of psychopharmacology … 2005 176 件の引用
Prescrire international 2005 2 件の引用
Nutrition journal 2004 72 件の引用
Revista de neurologia 2002 35 件の引用
Psychosomatic medicine 1999 136 件の引用
Postgraduate medical journal 1998 17 件の引用
American family physician 1997
Electroencephalography and clinical … 1984 2 件の引用

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

一般的な使用量

sleep:
600-1,000 mg DHA/day
general:
250-500 mg EPA+DHA/day

上限量: 3,000 mg/day EPA+DHA

研究で検討された用量

用量 期間 効果 N
LEO 25.0% concentration via inhalation during light phase -- Positive --
60 and 100 mg/kg (mice); 100 and 200 µg/mL (HT-22 cells); withanolide A 1.56 and 3.12 µg/mL -- Positive --
Mediterranean diet (high adherence vs. low adherence); polyphenols, omega-3, fiber as key components -- Positive --
tryptophan, carbohydrates, omega-3, vitamins (B6, B12, folate, niacin, D, C, beta-carotene), mineral -- Positive --
125 mg Zenroot (Ashwagandha with 1.5% total withanolides) daily 12 weeks Positive 90
Ashwagandha extract 600 mg/day (prior to discontinuation) -- Negative 1
Not applicable (Mendelian randomization using genetic instruments/SNPs) -- Positive --
600 mg/day (median) 8 weeks Positive 713

推奨摂取タイミング: With a meal; morning or evening

Safety & Side Effects

報告されている副作用

  • Fishy aftertaste or burps
  • GI upset
  • Diarrhea
  • Easy bruising at high doses

既知の相互作用

  • Blood thinners (warfarin) — omega-3 may enhance anticoagulant effects
  • Blood pressure medications — additive hypotensive effects
  • Orlistat — may reduce omega-3 absorption

耐容上限摂取量: 3,000 mg/day EPA+DHA

サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。

Frequently Asked Questions

Does オメガ3脂肪酸 help with 不眠症?
Based on 93 studies with 37,338 participants, there is strong evidence from multiple clinical trials that オメガ3脂肪酸 may support 不眠症 management. Our evidence grade is A (Strong Evidence).
How much オメガ3脂肪酸 should I take for 不眠症?
Studies have used various dosages. A commonly studied range is 600-1,000 mg DHA/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of オメガ3脂肪酸?
Reported side effects may include Fishy aftertaste or burps, GI upset, Diarrhea, Easy bruising at high doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for オメガ3脂肪酸 and 不眠症?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 93 peer-reviewed studies with 37,338 total participants. The overall direction of effect is positive.

Related Evidence

FDAに関する免責事項: これらの記述は米国食品医薬品局(FDA)による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。